These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11008656)

  • 61. Concomitant occurrence of leprosy and tuberculosis: leprosy vaccine, a myth or reality?
    Seghal VN; Jain S
    Lepr Rev; 1995 Jun; 66(2):179-81. PubMed ID: 7637529
    [No Abstract]   [Full Text] [Related]  

  • 62. [Infection by the human immunodeficiency virus and leprosy].
    Serme AK
    Med Trop (Mars); 1992; 52(3):245-50. PubMed ID: 1435184
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interactions between HIV infection and leprosy: a paradox.
    Ustianowski AP; Lawn SD; Lockwood DN
    Lancet Infect Dis; 2006 Jun; 6(6):350-60. PubMed ID: 16728321
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pathology of eye in leprosy.
    Job CK; Ebenezer GJ; Thompson K; Daniel E
    Indian J Lepr; 1998; 70(1):79-91. PubMed ID: 9598408
    [No Abstract]   [Full Text] [Related]  

  • 65. Suppression of ADCC by immune complexes formed in vitro in Mycobacterium leprae-infected mice.
    Vaishnavi C; Ganguly NK; Kaur S; Kumar B
    Microbiol Immunol; 1993; 37(1):49-53. PubMed ID: 8474357
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The study of Mycobacterium leprae infection in interferon-gamma gene--disrupted mice as a model to explore the immunopathologic spectrum of leprosy.
    Adams LB; Scollard DM; Ray NA; Cooper AM; Frank AA; Orme IM; Krahenbuhl JL
    J Infect Dis; 2002 Feb; 185 Suppl 1():S1-8. PubMed ID: 11865434
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Concurrent leprosy and HIV infection: a report of three cases.
    Sayal SK; Das AL; Gupta CM
    Indian J Lepr; 1997; 69(3):261-5. PubMed ID: 9394175
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative characteristics of antigenic profile of M. leprae and M. lufu.
    Salamatina OS; Dyachina MN; Juscenko AA; Parshin MP; Chernoyusova LN
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):39-43. PubMed ID: 11480317
    [No Abstract]   [Full Text] [Related]  

  • 69. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.
    Rambukkana A; Zanazzi G; Tapinos N; Salzer JL
    Science; 2002 May; 296(5569):927-31. PubMed ID: 11988579
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emergence of an effective adaptive cell mediated immune response to Mycobacterium leprae is not impaired in reactive oxygen intermediate-deficient mice.
    Hagge DA; Marks VT; Ray NA; Dietrich MA; Kearney MT; Scollard DM; Krahenbuhl JL; Adams LB
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):92-101. PubMed ID: 17645529
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
    Salamatina OS; Diachina MN; Iushchenko AA; Chernousova LN; Kalinina ON; Parshin MP
    Probl Tuberk; 2001; (8):49-51. PubMed ID: 11767394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mycobacterium leprae and the host response.
    Harboe M
    Lepr Rev; 1981 Dec; 52 Suppl 1():1-14. PubMed ID: 7040872
    [No Abstract]   [Full Text] [Related]  

  • 73. Long-term follow-up of co-infected HIV and Trypanosoma cruzi Brazilian patients.
    Da-Cruz AM; Igreja RP; Dantas W; Junqueira AC; Pacheco RS; Silva-Gonçalves AJ; Pirmez C
    Trans R Soc Trop Med Hyg; 2004 Dec; 98(12):728-33. PubMed ID: 15485703
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The role of the macrophage in resistance to the leprosy bacillus.
    Krahenbuhl JL; Adams LB
    Immunol Ser; 1994; 60():281-302. PubMed ID: 8251574
    [No Abstract]   [Full Text] [Related]  

  • 76. New insights and tools to combat leprosy nerve damage.
    Ottenhoff TH
    Lepr Rev; 2011 Dec; 82(4):334-7. PubMed ID: 22439272
    [No Abstract]   [Full Text] [Related]  

  • 77. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
    Oxenius A; Price DA; Günthard HF; Dawson SJ; Fagard C; Perrin L; Fischer M; Weber R; Plana M; García F; Hirschel B; McLean A; Phillips RE
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13747-52. PubMed ID: 12370434
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mechanism of immunosuppression in leprosy--macrophage membrane alterations.
    Salgame PR; Birdi TJ; Lad SJ; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Jul; 14(3):145-9. PubMed ID: 6384522
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The expression of FOXP3 in lesions of several forms of leprosy in patients co-infected with HIV.
    Xavier MB; Pires CAA; Gomes CMC; Rodrigues GF; Xavier DP; Brito JAGSM; Corbett CEP
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009887. PubMed ID: 34748560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Genetic component of the immune response to Mycobacterium leprae in healthy subjects].
    Bottasso OA; Hinrichsen L; Morini JC; Rabasa SL
    Medicina (B Aires); 1986; 46(6):713-8. PubMed ID: 3306256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.